Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common prostate drug help lewy body dementia?

NCT ID NCT04760860

First seen Mar 15, 2026 · Last updated May 23, 2026 · Updated 8 times

Summary

This early-stage trial tests whether terazosin, a drug used for prostate issues, is safe and tolerable for people with dementia with Lewy bodies. About 40 participants will receive either the drug or a placebo. The study focuses on side effects and how well people stick with the treatment, not on curing the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Iowa

    Iowa City, Iowa, 52252, United States

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.